The role of second-line chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer

Second Line ◽

Role of second-line chemotherapy in advanced pancreatic cancer and its influence on phase II/III study results

Annals of Oncology ◽

10.1093/annonc/mdt296 ◽

2013 ◽

Vol 24 (9) ◽

pp. 2462-2463

Author(s):

M. Teo ◽

R.S. McDermott

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Second Line ◽

Study Results ◽

FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-012-1875-1 ◽

2012 ◽

Vol 69 (6) ◽

pp. 1641-1645 ◽

Cited By ~ 41

Author(s):

Alberto Zaniboni ◽

Enrico Aitini ◽

Sandro Barni ◽

Daris Ferrari ◽

Stefano Cascinu ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Second Line ◽

Multicenter Phase ◽

Second-line chemotherapy in advanced pancreatic cancer patients before nab-paclitaxel introduction. Retrospective study in Reggio Emilia Clinical Cancer Centre

Annals of Oncology ◽

10.1093/annonc/mdw333.20 ◽

2016 ◽

Vol 27 ◽

pp. iv23

Author(s):

L. Baldi ◽

M. Panebianco ◽

P. Giorgi Rossi ◽

E. Di Felice ◽

T. Cassetti ◽

...

Keyword(s):

Pancreatic Cancer ◽

Retrospective Study ◽

Cancer Patients ◽

Reggio Emilia ◽

Second Line ◽

Cancer Centre ◽

Clinical Cancer ◽

Prognostic factors for time to progression and residual survival under second-line chemotherapy in advanced pancreatic cancer

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.15631 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 15631-15631

Author(s):

C. Herrmann ◽

U. Abel ◽

W. Stremmel ◽

D. Jaeger ◽

T. Herrmann

Keyword(s):

Pancreatic Cancer ◽

Prognostic Factors ◽

Second Line ◽

Time To Progression ◽

5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Advanced Pancreatic Cancer Who Have Progressed on Gemcitabine-Based Therapy

Chemotherapy ◽

10.1159/000356158 ◽

2013 ◽

Vol 59 (4) ◽

pp. 273-279 ◽

Cited By ~ 31

Author(s):

Min Geun Lee ◽

Sang Hyub Lee ◽

Seung June Lee ◽

Yoon Suk Lee ◽

Jin-Hyeok Hwang ◽

...

Keyword(s):

Pancreatic Cancer ◽

Second Line ◽

P-0119 Beneficial Trends of Second Line Chemotherapy in Advanced Pancreatic Cancer

Annals of Oncology ◽

10.1016/s0923-7534(20)30038-7 ◽

2012 ◽

Vol 23 ◽

pp. iv65

Author(s):

Milton Jose Barros e Silva ◽

Joyce Maria L. Maia ◽

Adriana Regina Goncalves Ribeiro ◽

Ludmilla T.D. Chinen ◽

Tadeu Paiva Junior ◽

...

Keyword(s):

Pancreatic Cancer ◽

Second Line ◽

Second-Line Chemotherapy in Advanced Pancreatic Cancer

Pancreatic Cancer - Recent Results in Cancer Research ◽

10.1007/978-3-540-71279-4_8 ◽

2007 ◽

pp. 61-64 ◽

Cited By ~ 2

Author(s):

Uwe Pelzer

Keyword(s):

Pancreatic Cancer ◽

Second Line ◽

Short Time to Progression under First-Line Chemotherapy Is a Negative Prognostic Factor for Time to Progression and Residual Survival under Second-Line Chemotherapy in Advanced Pancreatic Cancer

Oncology ◽

10.1159/000134477 ◽

2007 ◽

Vol 73 (5-6) ◽

pp. 335-339 ◽

Cited By ~ 14

Author(s):

Christina Herrmann ◽

Ulrich Abel ◽

Wolfgang Stremmel ◽

Dirk Jaeger ◽

Thomas Herrmann

Keyword(s):

Pancreatic Cancer ◽

Prognostic Factor ◽

Second Line ◽

Time To Progression ◽

First Line ◽

Negative Prognostic Factor ◽

Short Time ◽

Randomized Phase II Study of Consecutive-Day versus Alternate-Day Treatment with S-1 as Second-Line Chemotherapy in Advanced Pancreatic Cancer

Oncology ◽

10.1159/000492388 ◽

2018 ◽

Vol 96 (1) ◽

pp. 1-7

Author(s):

Takuya Ishikawa ◽

Hiroki Kawashima ◽

Eizaburo Ohno ◽

Hiroshi Matsubara ◽

Yoji Sasaki ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Day Treatment ◽

Second Line ◽

Randomized Phase Ii ◽

XELOX versus FOLFOX4 as Second Line Chemotherapy in Advanced Pancreatic Cancer

Hepatogastroenterology ◽

10.5754/hge12181 ◽

2012 ◽

Cited By ~ 1

Author(s):

Veli Berk ◽

Nuriye Ozdemir ◽

Metin Ozkan ◽

Sercan Aksoy ◽

Nedim Turan ◽

...

Keyword(s):

Pancreatic Cancer ◽

Second Line ◽